Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR5D13 Inhibitors

OR5D13 is a member of the olfactory receptor family of genes, a class of genes that are essential for the sense of smell. This vast gene family encodes proteins that detect volatile compounds, which are recognized by the olfactory system and translated into the perception of odors. OR5D13, like other olfactory receptors, is expressed in the olfactory epithelium, where it plays a crucial role in odor recognition and signal transduction. The expression of olfactory receptor genes, including OR5D13, is tightly regulated at the molecular level. This regulation is a complex process involving various epigenetic mechanisms that can either promote or inhibit gene expression. Epigenetic modifications such as DNA methylation and histone acetylation are known to alter the chromatin structure, thereby controlling the accessibility of transcription factors to gene promoter regions. Downregulation of OR5D13 expression can occur through these epigenetic modifications, which may be induced by a range of chemical agents. The specific modulation of OR5D13 could have implications for olfactory function, but the precise mechanisms by which these agents act on OR5D13 remain an area of active research. In the context of chemical-induced inhibition of OR5D13, several compounds have been identified that could potentially downregulate its expression through various epigenetic pathways. Histone deacetylase inhibitors, such as Trichostatin A and Vorinostat, can cause histone hyperacetylation, leading to a state of chromatin that is less conducive to gene transcription. Similarly, DNA methyltransferase inhibitors like 5-Azacytidine and Decitabine might decrease DNA methylation levels at the OR5D13 promoter, potentially leading to gene silencing. Other chemicals, such as Mithramycin A, can interfere with the binding of transcription factors by attaching to specific DNA sequences, thereby inhibiting the initiation of transcription. Additionally, compounds like DZNep that target histone methyltransferase enzymes may also contribute to the silencing of OR5D13 by affecting histone methylation status. It is important to note that the inhibitory effects of these chemicals are subject to the intricacies of gene regulation and cellular context, highlighting the need for detailed studies to understand their influence on OR5D13 expression. Researchers continue to explore these chemical interactions to elucidate the regulatory networks governing olfactory receptors, which could further our fundamental understanding of olfaction and gene expression regulation.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A is a histone deacetylase inhibitor that may lead to a more condensed chromatin state around the OR5D13 gene locus, potentially reducing accessibility of the transcriptional machinery and thus downregulating OR5D13 expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

5-Azacytidine could decrease DNA methylation levels at the promoter of OR5D13, which might result in a silenced gene state by attracting methyl-binding domain proteins that recruit co-repressor complexes to the OR5D13 locus.

MS-275

209783-80-2sc-279455
sc-279455A
sc-279455B
1 mg
5 mg
25 mg
$24.00
$90.00
$212.00
24
(2)

MS-275 suppresses histone deacetylase activity, which could lead to a decrease in transcriptional activity of the OR5D13 gene by promoting a chromatin structure that is less permissive for transcription factor binding and gene transcription.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

Suberoylanilide Hydroxamic Acid, by inhibiting histone deacetylase enzymes, may cause histone hyperacetylation at the OR5D13 site, resulting in chromatin remodeling that could lead to transcriptional repression of the OR5D13 gene.

Mithramycin A

18378-89-7sc-200909
1 mg
$55.00
6
(1)

Mithramycin A binds specifically to GC-rich DNA sequences, which could block the binding sites for essential transcription factors at the OR5D13 promoter, thereby inhibiting the initiation of its transcription.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

5-Aza-2′-Deoxycytidine is known to inhibit DNA methyltransferase, which might lead to a reduction in methylation at the OR5D13 promoter region, potentially triggering the recruitment of repressor proteins that silence gene expression.

Hydralazine-15N4 Hydrochloride

304-20-1 (unlabeled)sc-490605
1 mg
$480.00
(0)

Hydralazine may lead to DNA demethylation, which could contribute to a downregulation of OR5D13 by creating an unsuitable epigenetic environment for the expression of this gene.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic acid could act as a ligand for nuclear receptors that bind to retinoic acid response elements (RARE) in gene promoters, which might include the OR5D13 promoter, leading to a decrease in OR5D13 expression.

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$94.00
$213.00
33
(5)

Methotrexate, by reducing folate, could indirectly lead to a decrease in the methylation capacity of the cell, potentially resulting in the downregulation of OR5D13 expression due to altered epigenetic states.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Disulfiram can inhibit DNA methyltransferase, potentially decreasing the methylation status of the OR5D13 gene region and leading to the recruitment of transcriptional repressors that inhibit the gene′s expression.